Fulvio Loiodice
- Molecular Biology top 5%
- Organic Chemistry top 5%
- Pharmacology top 2%
- Oncology top 10%
- Spectroscopy top 5%
- Co-authors
- Antonio LaghezzaPaolo TortorellaGiuseppe FracchiollaAntonio LavecchiaLuca PiemonteseG. PochettiRoberta MontanariDiana Conte Camerino
- Topics
- Peroxisome Proliferator-Activated Receptors (43 papers)Metabolism, Diabetes, and Cancer (21 papers)Analytical Chemistry and Chromatography (20 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryAnalytical Chemistry
- Partner nations
- ItalyUnited StatesIndia
In The Last Decade
Fulvio Loiodice
116 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 109
- Molecular Biology 1.7k
- Organic Chemistry 586
- Pharmacology 396
- Oncology 317
- Spectroscopy 291
Countries citing papers authored by Fulvio Loiodice
This map shows the geographic impact of Fulvio Loiodice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fulvio Loiodice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fulvio Loiodice more than expected).
Fields of papers citing papers by Fulvio Loiodice
This network shows the impact of papers produced by Fulvio Loiodice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fulvio Loiodice. The network helps show where Fulvio Loiodice may publish in the future.
Co-authorship network of co-authors of Fulvio Loiodice
This figure shows the co-authorship network connecting the top 25 collaborators of Fulvio Loiodice. A scholar is included among the top collaborators of Fulvio Loiodice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fulvio Loiodice. Fulvio Loiodice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 5 | |
| 6 | 27 | |
| 7 | 7 | |
| 8 | 18 | |
| 9 | 5 | |
| 10 | 11 | |
| 11 | 29 | |
| 12 | 3 | |
| 13 | 16 | |
| 14 | 3 | |
| 15 | 39 | |
| 16 | 26 | |
| 17 | 25 | |
| 18 | 5 | |
| 19 | 33 | |
| 20 | 32 |
About Fulvio Loiodice
Fulvio Loiodice is a scholar working on Biochemistry, Molecular Biology and Spectroscopy, having authored 117 papers that have together received 2.7k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (43 papers), Metabolism, Diabetes, and Cancer (21 papers) and Analytical Chemistry and Chromatography (20 papers). The work is most often cited by research in Biochemistry (195 citations), Molecular Biology (1.7k citations) and Pharmacology (396 citations). Fulvio Loiodice has collaborated with scholars based in Italy, United States and India. Frequent co-authors include Antonio Laghezza, Paolo Tortorella, Giuseppe Fracchiolla, Antonio Lavecchia, Luca Piemontese, G. Pochetti, Roberta Montanari, Diana Conte Camerino, Vincenzo Tortorella and Enrica Calleri. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.